Financial News
Articles published by Pfizer Inc.
![](https://mms.businesswire.com/media/20230918178824/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts
September 18, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230912226526/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
September 12, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230907854671/en/1670922/22/pfizer-biontech-logos.jpg)
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
September 11, 2023
From Pfizer Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230905113646/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
September 05, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230829323192/en/1878095/22/BioNTech_Logo.jpg)
![](https://mms.businesswire.com/media/20230830525102/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences
August 30, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230822321932/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230821069057/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230809028227/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma
August 14, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230801290631/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Reports Second-Quarter 2023 Results
August 01, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230726258329/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy
July 27, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230721485341/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility
July 21, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230719771519/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230627678641/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230627431780/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
FDA Accepts Pfizer’s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec
June 27, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230625157557/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230623087591/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata
June 23, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230622461145/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Declares Third-Quarter 2023 Dividend
June 22, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230615555231/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230620765035/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to View and Listen to Webcast of August 1 Conference Call with Analysts
June 20, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230606005032/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
June 06, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230601005216/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230530005660/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230530005109/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B Trial
May 30, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230525005684/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Presents Scientific Advancements from its Leading Oncology Portfolio at ASCO 2023 Annual Meeting
May 25, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230525005573/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230518005725/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230516005960/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Prices $31,000,000,000 Debt Offering
May 16, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230514005054/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Announces Proposed Notes Offering
May 15, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20230502005284/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Reports First-Quarter 2023 Results
May 02, 2023
From Pfizer Inc.
Via Business Wire
Tickers
PFE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.